These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 10851542)

  • 1. Alpha interferon-2b, leucovorin, and 5-fluorouracil (ALF) in non-small cell lung cancer.
    Quan WD; Casal R; Rosenfeld M; Walker PR
    Cancer Biother Radiopharm; 1996 Aug; 11(4):229-34. PubMed ID: 10851542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha interferon, leucovorin, and 5-fluorouracil (ALF) in advanced cancer: results of a dose-finding study and evidence of activity in non-small cell lung cancer.
    Quan WD; Madajewicz S; Smith MR; Skeel RT
    Cancer Invest; 1994; 12(4):367-74. PubMed ID: 8032955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weekly 5-fluorouracil and interferon-alfa-2b in metastatic cancer.
    Quan WD; Casal R
    Cancer Biother Radiopharm; 1996 Jun; 11(3):187-91. PubMed ID: 10851536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
    Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
    Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ifosfamide-based chemotherapy for previously treated lung cancer patients.
    Chen YM; Liu JM; Wu MF; Wu HW; Lin WC; Tsai CM; Perng RP; Whang-Peng J
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jul; 61(7):389-96. PubMed ID: 9699391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
    Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Three cases of lung metastases of renal cell carcinoma treated with a combination of interferon-alpha, 5-fluorouracil and leucovorin].
    Togashi M; Tabata T; Hirakawa K; Ohashi N; Sindoh J; Hirano T; Demura T
    Hinyokika Kiyo; 1996 Jan; 42(1):43-5. PubMed ID: 8686582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292).
    Hudes GR; Lipsitz S; Grem J; Morrisey M; Weiner L; Kugler JW; Benson A
    Cancer; 1999 Jan; 85(2):290-4. PubMed ID: 10023694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent 5-fluorouracil, leucovorin, etoposide, cisplatin and radiotherapy for locally advanced non-small cell lung cancer.
    Yang CT; Chang WC; Chen LH; Leung WM; Lee CH; Liaw CC
    Changgeng Yi Xue Za Zhi; 1997 Sep; 20(3):187-94. PubMed ID: 9397609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I trial of fluorouracil, leucovorin, and recombinant interferon alpha-2b in patients with advanced malignancy.
    Taylor CW; Modiano MR; Woodson ME; Marcus SG; Alberts DS; Hersh EM
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):185-90. PubMed ID: 1557645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma.
    Kreuser ED; Hilgenfeld RU; Matthias M; Hoksch B; Boewer C; Oldenkott B; Lenk H; Wiener N; Boese-Landgraf J; Schalhorn A
    Semin Oncol; 1992 Apr; 19(2 Suppl 4):57-62. PubMed ID: 1553576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etoposide, leucovorin, 5-fluorouracil and interferon alpha-2b in elderly gastric cancer patients: a pilot study.
    Cascinu S; Fedeli A; Catalano G
    Cancer Chemother Pharmacol; 1994; 34(1):72-4. PubMed ID: 8174205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative phase II study of 5-fluorouracil with high-dose leucovorin in non-small cell lung cancer.
    Ohe Y; Shinkai T; Eguchi K; Sasaki Y; Tamura T; Nakagawa K; Kojima A; Yamada K; Oshita F; Miya T
    Jpn J Clin Oncol; 1990 Dec; 20(4):364-8. PubMed ID: 2178196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II study of oxaliplatin in combination with leucovorin and fluorouracil as first-line chemotherapy in patients with metastatic squamous cell carcinoma of esophagus.
    Wang J; Chang J; Yu H; Wu X; Wang H; Li W; Ji D; Peng W
    Cancer Chemother Pharmacol; 2013 Apr; 71(4):905-11. PubMed ID: 23370661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral UFT, etoposide and leucovorin in recurrent non-small cell lung cancer: a non-randomized phase II study.
    Surmont V; Aerts JG; Pouw E; Tan KY; Vernhout R; Gras J; Salomé J; Pronk T; Schmitz PI; Hoogsteden H; van Klaveren RJ
    Lung Cancer; 2009 Dec; 66(3):333-7. PubMed ID: 19327865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of two different cisplatin-based chemotherapy regimens on advanced non-small cell lung cancer.
    Chen CH; Yang CT; Chang WJ; Liaw CC; Tsao TC
    Changgeng Yi Xue Za Zhi; 1999 Jun; 22(2):220-6. PubMed ID: 10493026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II trial of 5-fluorouracil and high-dose leucovorin in gastric carcinoma and a phase I trial of intraperitoneal 5-fluorouracil and leucovorin.
    Arbuck SG; Douglass HO; Trave F; Rustum YM
    NCI Monogr; 1987; (5):203-5. PubMed ID: 3501544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination immunochemotherapy of 5-fluorouracil, cisplatin, leucovorin, and OK-432 for advanced and recurrent gastric carcinoma.
    Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y
    Hepatogastroenterology; 2003; 50(54):2259-63. PubMed ID: 14696512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II clinical trial of S-1 plus oral leucovorin in previously treated patients with non-small-cell lung cancer.
    Naito T; Seto T; Takeda K; Goto K; Okamoto I; Nakagawa K; Ohba T; Murakami H; Takahashi T; Yamanaka T; Yamamoto N
    Lung Cancer; 2014 Dec; 86(3):339-43. PubMed ID: 25453619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of 5-fluorouracil, leucovorin, interferon-alpha-2a, and cisplatin as neoadjuvant chemotherapy for locally advanced esophageal carcinoma.
    Temeck BK; Liebmann JE; Theodossiou C; Steinberg SM; Cook JA; Metz DC; Shawker TH; Allegra CJ; Russo A; Pass HI
    Cancer; 1996 Jun; 77(12):2432-9. PubMed ID: 8640689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.